Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs
- PMID: 25603423
- DOI: 10.1016/j.pharmthera.2015.01.008
Anti-tumor activities of lipids and lipid analogues and their development as potential anticancer drugs
Abstract
Lipids have the potential for development as anticancer agents. Endogenous membrane lipids, such as ceramides and certain saturated fatty acids, have been found to modulate the viability of tumor cells. In addition, many tumors over-express cyclooxygenase, lipoxygenase or cytochrome P450 enzymes that mediate the biotransformation of ω-6 polyunsaturated fatty acids (PUFAs) to potent eicosanoid regulators of tumor cell proliferation and cell death. In contrast, several analogous products from the biotransformation of ω-3 PUFAs impair particular tumorigenic pathways. For example, the ω-3 17,18-epoxide of eicosapentaenoic acid activates anti-proliferative and proapoptotic signaling cascades in tumor cells and the lipoxygenase-derived resolvins are effective inhibitors of inflammatory pathways that may drive tumor expansion. However, the development of potential anti-cancer drugs based on these molecules is complex, with in vivo stability a major issue. Nevertheless, recent successes with the antitumor alkyl phospholipids, which are synthetic analogues of naturally-occurring membrane phospholipid esters, have provided the impetus for development of further molecules. The alkyl phospholipids have been tested against a range of cancers and show considerable activity against skin cancers and certain leukemias. Very recently, it has been shown that combination strategies, in which alkyl phospholipids are used in conjunction with established anticancer agents, are promising new therapeutic approaches. In future, the evaluation of new lipid-based molecules in single-agent and combination treatments may also be assessed. This could provide a range of important treatment options in the management of advanced and metastatic cancer.
Keywords: Alkyl phospholipid; Epoxide isostere; Lipid-based anticancer agent; PUFA epoxide; Tumor apoptosis; Tumor proliferation.
Copyright © 2015 Elsevier Inc. All rights reserved.
Similar articles
-
Lipid analogues as potential drugs for the regulation of mitochondrial cell death.Br J Pharmacol. 2014 Apr;171(8):2051-66. doi: 10.1111/bph.12417. Br J Pharmacol. 2014. PMID: 24111728 Free PMC article. Review.
-
The anticancer effects of Vitamin D and omega-3 PUFAs in combination via cod-liver oil: one plus one may equal more than two.Med Hypotheses. 2011 Sep;77(3):326-32. doi: 10.1016/j.mehy.2011.05.006. Epub 2011 May 31. Med Hypotheses. 2011. PMID: 21632182 Review.
-
Marine lipids: overview "news insights and lipid composition of Lyprinol".Allerg Immunol (Paris). 2000 Sep;32(7):261-71. Allerg Immunol (Paris). 2000. PMID: 11094639 Review.
-
Differential effects of lipid fractions from silver carp brain on human cervical carcinoma cells in vitro.Food Funct. 2014 Sep;5(9):2194-201. doi: 10.1039/c4fo00168k. Food Funct. 2014. PMID: 25047635
-
[Fatty acids as a potentially helpful supplement in cancer therapy].Postepy Hig Med Dosw. 2002;56(5):589-602. Postepy Hig Med Dosw. 2002. PMID: 12587427 Review. Polish.
Cited by
-
Investigation of miltefosine-model membranes interactions at the molecular level for two different PS levels modeling cancer cells.J Bioenerg Biomembr. 2024 Aug;56(4):461-473. doi: 10.1007/s10863-024-10025-y. Epub 2024 Jun 4. J Bioenerg Biomembr. 2024. PMID: 38833041 Free PMC article.
-
Glycometabolism and lipid metabolism related genes predict the prognosis of endometrial carcinoma and their effects on tumor cells.BMC Cancer. 2024 May 8;24(1):571. doi: 10.1186/s12885-024-12327-1. BMC Cancer. 2024. PMID: 38720279 Free PMC article.
-
Photodynamic Therapy Supported by Antitumor Lipids.Pharmaceutics. 2023 Dec 3;15(12):2723. doi: 10.3390/pharmaceutics15122723. Pharmaceutics. 2023. PMID: 38140064 Free PMC article.
-
Electrochemical flow aziridination of unactivated alkenes.Natl Sci Rev. 2023 Jul 3;10(10):nwad187. doi: 10.1093/nsr/nwad187. eCollection 2023 Oct. Natl Sci Rev. 2023. PMID: 38059062 Free PMC article.
-
The clinical application of atorvastatin in patients with small-cell lung cancer with dyslipidemia.J Cancer Res Clin Oncol. 2023 Nov;149(15):13697-13704. doi: 10.1007/s00432-023-05102-5. Epub 2023 Jul 31. J Cancer Res Clin Oncol. 2023. PMID: 37522924
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources